VLA 0.00% $1.75 viralytics limited

This cake is baked, page-4

  1. 47 Posts.
    Prior to Tuesday, Viralytics were aware of their clinical trial results in combination with Yervoy and Keytruda. Merck were aware of the Keytruda results, and BMS were aware of the Yervoy results. On Tuesday Merck and BMS found out about each others' results. On that day you would think the deal price went up and the waiting time went down.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.